| (Values in U.S. Thousands) | Mar, 2026 | Mar, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 |
| Sales | 19,640 | 1,570 | 3,850 | 1,570 | 2,970 |
| Sales Growth | +1,150.95% | -59.22% | +145.22% | -47.14% | +26.92% |
| Net Income | -16,630 | -7,450 | -157,320 | -115,770 | -102,260 |
| Net Income Growth | -123.22% | +95.26% | -35.89% | -13.21% | -27.19% |
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31